Cardiac Disease in Pregnancy D

Total Page:16

File Type:pdf, Size:1020Kb

Cardiac Disease in Pregnancy D 14 Chapter 2 Cardiac disease in pregnancy D. L. Adamson, M. K. Dhanjal, C. Nelson-Piercy, R. Collis SYNOPSIS Heart disease and its management in obstetrics Aortic dissection Introduction Ischemic heart disease Physiological changes in pregnancy Arrhythmias Normal fi ndings on examination of the Obstetric anesthetic management of the mother with cardiovascular system in pregnancy cardiac disease Cardiac investigations in pregnancy Anesthetic antenatal assessment and classifi cation Congenital heart disease of mother with cardiac disease Acquired heart disease Anesthetic interventions Endocarditis prophylaxis Anesthetic techniques Heart disease and its management in obstetrics D. L. Adamson, M. K. Dhanjal, C. Nelson-Piercy INTRODUCTION disease has continued to rise in the UK since the early 1980s. The major causes of cardiac deaths over Pregnancies complicated by signifi cant heart disease the last 10 years are cardiomyopathy (predominantly are uncommon in the UK, Europe and the devel- peripartum), myocardial infarction (most commonly oped world. However cardiac disease is now the due to coronary artery dissection), dissection of the leading cause of maternal death in the UK. There thoracic aorta and pulmonary hypertension. In were 44 indirect deaths attributed to cardiac disease the UK, rheumatic heart disease is now rare in in 2000-2002, giving a death rate of 2.2 per 100 000 women of childbearing age and mostly confi ned to maternities. The maternal mortality rate from cardiac immigrants. CCh002-F10129.inddh002-F10129.indd 1144 44/26/2007/26/2007 22:05:44:05:44 PPMM HEART DISEASE AND ITS MANAGEMENT IN OBSTETRICS 15 Women with congenital heart disease are surviv- increase in cardiac pre-load (such as infusion of ing longer thanks to corrective or palliative surgery fl uids), increase in left atrial and pulmonary venous in childhood. They are therefore not uncommonly pressure (such as in mitral stenosis) or increased encountered in pregnancy. These women may have pulmonary capillary permeability (such as in pre- complicated pregnancies. Women with mechanical eclampsia), or a combination of these factors. prosthetic valves face diffi cult decisions regarding In late pregnancy in the supine position, pressure anticoagulation in pregnancy. of the gravid uterus on the inferior vena cava causes Because of signifi cant physiological changes in a reduction in venous return to the heart and a con- pregnancy, symptoms, such as palpitations, and signs sequent fall in stroke volume and cardiac output. such as an ejection systolic murmur are very common Turning from the lateral to the supine position may innocent fi ndings. Not all women with signifi cant result in a 25% reduction in cardiac output. Pregnant heart disease are able to meet these increased physio- women should therefore be nursed in the left or right logical demands. The care of the pregnant and lateral position wherever possible. If the mother has parturient woman with heart disease requires a mul- to be kept on her back, the pelvis should be rotated tidisciplinary approach, involving obstetricians, car- so that the uterus drops to the side and cardiac output diologists and anesthetists, preferably in a dedicated as well as uteroplacental blood fl ow are optimized. antenatal cardiac clinic. This allows formulation of an Reduced cardiac output is associated with a reduction agreed and documented management plan encom- in uterine blood fl ow and therefore in placental per- passing management of both planned and emergency fusion; this can compromise the fetus. delivery. Labor is associated with further increases in cardiac output (15% in the fi rst stage and 50% in the second stage). Uterine contractions lead to autotrans- fusion of 300-500 mL of blood back into the circula- PHYSIOLOGICAL CHANGES tion and the sympathetic response to pain and IN PREGNANCY anxiety further elevate heart rate and blood pressure. Cardiac output is increased more during contractions Blood volume starts to increase by the fi fth week after but also between contractions. The rise in stroke conception secondary to estrogen- and prostaglandin- volume with each contraction is attenuated by good induced relaxation of smooth muscle that increases pain relief and further reduced by epidural analgesia the capacitance of the venous bed. Plasma volume and the supine position. Epidural analgesia or anes- increases and red cell mass rises but to a lesser degree, thesia cause arterial vasodilation and a fall in blood thus explaining the physiological anemia of preg- pressure. General anesthesia is associated with a rise nancy. Relaxation of smooth muscle on the arterial in blood pressure and heart rate during induction, side results in a profound fall in systemic vascular but cardiovascular stability thereafter. Prostaglan- resistance and together with the increase in blood dins given to induce labor have little effect on volume, determines the early increase in cardiac hemodynamics but ergometrine causes vasocons- output. Blood pressure falls slightly but by term has triction and syntocinon can cause vasodilation and usually returned to the pre-pregnancy value. The fl uid retention. increased cardiac output is achieved by an increase in Following delivery of the baby up to 1 L of blood stroke volume and a lesser increase in resting heart may be returned to the circulation due to the relief of rate of 10-20 beats/min. By the end of the second tri- inferior vena cava obstruction and contraction of the mester the blood volume and stroke volume have uterus. The intrathoracic and cardiac blood volumes risen by between 30 and 50%. This increase correlates rise, cardiac output increases by 60-80% followed by with the size and weight of the products of conception a rapid decline to pre-labor values within about 1 h and is therefore considerably greater in multiple of delivery. Transfer of fl uid from the extravascular pregnancies as is the risk of heart failure in heart space increases venous return and stroke volume disease. further. Those women with cardiovascular compro- Although there is no increase in pulmonary capil- mise are therefore most at risk of pulmonary edema lary wedge pressure (PCWP), plasma colloid oncotic during the second stage of labor and the immediate pressure is reduced. The colloid oncotic pressure- postpartum period. All the changes revert quite pulmonary capillary wedge pressure gradient is rapidly during the fi rst week and more slowly over reduced by 28%, making pregnant women particu- the following six weeks but even at a year signifi cant larly susceptible to pulmonary edema. Pulmonary changes still persist and are enhanced by a subse- edema may be precipitated if there is either an quent pregnancy. CCh002-F10129.inddh002-F10129.indd 1155 44/26/2007/26/2007 22:05:44:05:44 PPMM 16 CARDIAC DISEASE IN PREGNANCY NORMAL FINDINGS ON EXAMINATION a lesion which is associated with long-term survival OF THE CARDIOVASCULAR SYSTEM or because they have had successful surgery. Whilst IN PREGNANCY some may not be able to tolerate the hemodynamic changes of pregnancy, the majority will have enough Normal fi ndings on cardiovascular examination may cardiac reserve to carry a pregnancy to term. CHD is include a loud fi rst heart sound with exaggerated infrequently associated with maternal mortality, splitting of the second heart sound and a physiological however, there may be a signifi cant deterioration in third heart sound at the apex. A systolic ejection the maternal condition. These complex patients should murmur at the left sternal edge is heard in nearly all be jointly cared for by obstetricians, obstetric physi- women and may be remarkably loud and be audible cians and cardiologists with expertise in pregnancy all over the precordium. It varies with posture and if and adult congenital heart disease and provide a chal- unaccompanied by any other abnormality it refl ects lenge for such a team. the increased stroke output. Venous hums and mam- mary souffl es may be heard. Because of the peripheral vasodilation the pulse may be bounding and in addi- Pre-pregnancy counseling and assessment tion ectopic beats are very common in pregnancy. Most women with congenital heart disease are known to a cardiologist prior to pregnancy. It is extremely CARDIAC INVESTIGATIONS important that such women are appropriately coun- IN PREGNANCY seled about their individual health risks with preg- nancy. If pregnancy carries an unacceptable risk, this The electrocardiographic (ECG) axis shifts superiorly should be explained and appropriate contraceptive in late pregnancy due to a more horizontal position of advice given. Advising an individual may be diffi cult, the heart. Small Q-waves and T-wave inversion in the particularly those with corrected complex disease, as right precordial leads are not uncommon. Atrial and data remain sparse for pregnancy outcomes following ventricular ectopics are both common. some forms of corrective and palliative surgery. The amount of radiation received by the fetus Maternal risk of pregnancy is assessed by obtain- during a maternal chest X-ray (CXR) is negligible and ing an accurate history, which will defi ne the func- a CXR should never be withheld if clinically indicated tional status, examination and undertaking relevant in pregnancy. Transthoracic echocardiogram is the investigations. This also provides a baseline of the investigation of choice to exclude, confi rm or monitor cardiovascular status, allowing any change occurring structural heart disease in pregnancy. Transesopha- in pregnancy to be objectively
Recommended publications
  • Early Diastolic Clicks After the Fontan Procedure for Double
    304 Br Heart J 1990;63:304-7 Early diastolic clicks after the Fontan procedure for double inlet left ventricle: anatomical and physiological correlates Br Heart J: first published as 10.1136/hrt.63.5.304 on 1 May 1990. Downloaded from Andrew N Redlngton, Kit-Yee Chan, Julene S Carvalho, Elliot A Shinebourne Abstract inlet ventricle with two atrioventricular M mode echocardiograms and simultan- valves. All had previously undergone a Fontan eous phonocardiograms were recorded type procedure with direct atriopulmonary in four patients with early diastolic anastomosis. In two patients a valved clicks on auscultation. All had double homograft was interposed between the right inlet left ventricle and had undergone atrium and pulmonary artery. Each patient the Fontan procedure with closure of the had the right atrioventricular valve closed by right atrioventricular valve orifice by an either a single or double layer of Dacron cloth artifical patch. The phonocardiogram sewn into the floor of the right atrium. The confirmed a high frequency sound main pulmonary artery was tied off in all. occurring 60-90 ms after aortic valve Cross sectional, M mode, and pulsed wave closure and coinciding with the time of Doppler echocardiograms with simultaneous maximal excursion of the atrioven- electrocardiogram and phonocardiogram were tricular valve patch towards the ven- recorded on a Hewlett-Packard 77020A tricular mass. One patient had coexist- ultrasound system. The phonocardiogram was ing congenital complete heart block. recorded over the point on the chest where the The M mode echocardiogram showed diastolic click was best heart on auscultation, i'reversed") motion of the patch towards usually in the fourth left intercostal space the right atrium during atrial contrac- close to the sternum.
    [Show full text]
  • Modified Fontan Procedure: Extracardiac Conduit
    Normal Heart © 2012 The Children’s Heart Clinic NOTES: Children’s Heart Clinic, P.A., 2530 Chicago Avenue S, Ste 500, Minneapolis, MN 55404 West Metro: 612-813-8800 * East Metro: 651-220-8800 * Toll Free: 1-800-938-0301 * Fax: 612-813-8825 Children’s Minnesota, 2525 Chicago Avenue S, Minneapolis, MN 55404 West Metro: 612-813-6000 * East Metro: 651-220-6000 © 2012 The Children’s Heart Clinic Reviewed March 2019 Modified Fontan Procedure: Extracardiac Conduit The Fontan procedure is usually the third procedure done in a series of surgeries to complete palliation of single ventricle patients. This procedure separates the “blue,” deoxygenated blood from the “red,” oxygenated blood circuit. Once the Fontan is done, deoxygenated blood drains passively to the pulmonary arteries, then to the lungs. Blood receives oxygen from the lungs and returns to the heart, where it is actively pumped out to the body. This procedure is usually done between 2-4 years of age. During surgery, the chest is opened through the previous incision, using a median sternotomy. The operation may or may not involve the use of cardiopulmonary bypass (heart-lung machine), depending on the surgical plan. A Gore-tex® tube graft (Gore) is cut to the appropriate length. An incision is made on the pulmonary artery near the area of the existing bidirectional Glenn shunt (cavopulmonary anastomosis) and the tube graft is sutured to the artery. Once that is complete, the inferior vena cava is divided from the atrium. The lower end of the Gore-tex® tube graft (Gore) is then sutured to the inferior vena cava.
    [Show full text]
  • E001466.Full.Pdf
    Editorial BMJ Glob Health: first published as 10.1136/bmjgh-2019-001466 on 11 April 2019. Downloaded from WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one? Joshua P Vogel, 1,2 Myfanwy Williams,3 Ioannis Gallos,4 Fernando Althabe,1 Olufemi T Oladapo1 To cite: Vogel JP, THE GLOBAL BURDEN OF POSTPARTUM trials of tranexamic acid for PPH treatment Williams M, Gallos I, et al. HAEMORRHAGE and a heat-stable formulation of carbetocin WHO recommendations on 6–12 uterotonics for postpartum Obstetric haemorrhage, especially post- for PPH prevention. The increasing haemorrhage prevention: partum haemorrhage (PPH), was responsible number of PPH prevention and management what works, and which for more than a quarter of the estimated 303 options makes it challenging for providers one?BMJ Glob Health 000 maternal deaths that occurred globally in and health system stakeholders to choose 2019;4:e001466. doi:10.1136/ 2015.1 PPH—commonly defined as a blood where and how to invest limited resources in bmjgh-2019-001466 loss of 500 mL or more within 24 hours after order to optimise health outcomes. birth—affects about 6% of all women giving Multiple uterotonics have been eval- Handling editor Seye Abimbola birth.1 Uterine atony is the most common uated for PPH prevention over the past Received 4 February 2019 cause of PPH, but it can also be caused by four decades, including oxytocin receptor Revised 10 March 2019 genital tract trauma, retained placental tissue agonists (oxytocin and carbetocin), prosta- Accepted 16 March 2019 or maternal bleeding disorders. The majority glandin analogues (misoprostol, sulprostone, of women who experience PPH have no iden- carboprost), ergot alkaloids (such as ergo- tifiable risk factor, meaning that PPH preven- metrine/methylergometrine) and combina- tion programmes rely on universal use of PPH tions of these (oxytocin plus ergometrine, © Author(s) (or their prophylaxis for all women in the immediate or oxytocin plus misoprostol).
    [Show full text]
  • New Zealand Data Sheet
    NEW ZEALAND DATA SHEET 1. PRODUCT NAME PROSTIN 15M 250 microgram (µg)/mL Solution for Injection 2. QUALITATIVE AND QUANTITIATIVE COMPOSITION Each 1 mL contains 250 μg carboprost or 332 μg carboprost (as tromethamine). Excipient(s) with known effect Each 1 mL contains 9.45 mg/mL benzyl alcohol (added as preservative). For the full list of excipients, see section 6.1. 3. PHARMACEUTIAL FORM Solution for Injection. PROSTIN 15M is a clear colourless solution. 4. CLINCAL PARTICUALRS 4.1 Therapeutic indications PROSTIN 15M is indicated for the treatment of postpartum haemorrhage due to uterine atony which has not responded to conventional methods of management. Prior treatment should include the use of intravenously administered oxytocin, manipulative techniques such as uterine massage and, unless contraindicated, intramuscular ergot preparations. Studies have shown that in such cases, the use of PROSTIN 15M has resulted in satisfactory control of haemorrhage, although it is unclear whether or not ongoing or delayed effects of previously administered embolic agents have contributed to the outcome. In a high proportion of cases, PROSTIN 15M used in this manner has resulted in the cessation of life threatening bleeding and the avoidance of emergency surgical intervention. 4.2 Dose and method of administration Dose An initial dose of 250 µg (1 mL) is to be given by deep intramuscular injection. In clinical trials, it was found that the majority of successful cases (73%) responded to single injections. In some selected cases, however, multiple dosing at intervals of 15 to 90 minutes was carried out with successful outcome. The need for additional injections and the interval at which these should be given can be determined only by the attending physicians as dictated by the course of clinical events.
    [Show full text]
  • The Physiology of the Fontan Circulation ⁎ Andrew Redington
    Progress in Pediatric Cardiology 22 (2006) 179–186 www.elsevier.com/locate/ppedcard The physiology of the Fontan circulation ⁎ Andrew Redington Division of Cardiology, The Department of Pediatrics, The Hospital for Sick Children, University of Toronto School of Medicine, Toronto, Ontario, Canada Available online 8 September 2006 Abstract The Fontan circulation, no matter which of its various iterations, is abnormal in virtually every aspect of its performance. Some of these abnormalities are primarily the result of the procedure itself, and others are secondary to the fundamental disturbances of circulatory performance imposed by the ‘single’ ventricle circulation. The physiology of ventricular, systemic arterial and venopulmonary function will be described in this review. © 2006 Elsevier Ireland Ltd. All rights reserved. Keywords: palliation; Fontan circulation; Cavopulmonary anastomosis; Antriopulmonary anastomosis 1. Introduction has the profound consequences for the systemic ventricle that will discussed below. At the same time as the bidirectional In this personal overview, I will discuss the physiology of the cavopulmonary anastomosis was becoming almost uniformly Fontan circulation. Bob Freedom's contribution to our under- adopted, there was abandonment of the ‘classical’ atriopulmon- standing of complex congenital heart disease has meant that ary anastomosis, in favour of the total cavopulmonary con- many more of these patients are surviving with this physiology nection (TCPC). The ‘lateral wall’ TCPC, popularised by Marc than could have been contemplated 30 years ago. Nonetheless, deLeval [1], was shown experimentally and clinically to be they represent a very difficult group of patients and we continue haemodynamically more efficient [1,2] and set the scene for the to learn more about this unique circulation.
    [Show full text]
  • Eicosanoids & Platelet Activating Factor
    Eicosanoids & Platelet Activating Factor Prof. Sanjay Khattri Dept. of Pharmacology & Therapeutics King George’s Medical University, Lucknow 1 Autacoid These are the substances produced by wide variety of cells that act locally at the site of production. (local hormones) 2 Mediators of Inflammation and Immune reaction 1. Vasoactive amines (Histamine and Serotonin) 2.Eicosanoids 3.Platlet Activating Factor 4.Bradykinins 4.Nitric Oxide 5.Neuropeptides 6.Cytokinines 3 EICOSANOIDS PGs, TXs and LTs are all derived from eicosa (referring to 20 C atoms) tri/tetra/ penta enoic acids. Therefore, they can be collectively called eicosanoids. Major source: 5,8,11,14 eicosa tetraenoic acid (arachidonic acid). Other eicosanoids of increasing interest are: lipoxins and resolvins. The term prostanoid encompasses both prostaglandins and thromboxanes. 4 EICOSANOIDS Contd…. In most instances, the initial and rate-limiting step in eicosanoid synthesis is the liberation of intracellular arachidonate, usually in a one-step process catalyzed by the enzyme phospholipase A2 (PLA2). PLA2 generates not only arachidonic acid but also lysoglyceryl - phosphorylcholine (lyso-PAF), the precursor of platelet activating factor (PAF). 5 EICOSANOIDS Contd…. Corticosteroids inhibit the enzyme PLA2 by inducing the production of lipocortins (annexins). The free arachidonic acid is metabolised separately (or sometimes jointly) by several pathways, including the following: Cyclo-oxygenase (COX)- Two main isoforms exist, COX-1 and COX-2 Lipoxygenases- Several subtypes, which
    [Show full text]
  • Product Monograph
    PRODUCT MONOGRAPH HEMABATE® STERILE SOLUTION (carboprost tromethamine injection USP) 250 µg/mL Prostaglandin Pfizer Canada Inc. Date of Revision: 17,300 Trans-Canada Highway February 21, 2014 Kirkland, Quebec H9J 2M5 Control No. 170114 ® Pfizer Enterprises SARL Pfizer Canada Inc, Licensee © Pfizer Canada Inc. 2014 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION ..........................................................3 SUMMARY OF PRODUCT INFORMATION ..................................................................3 INDICATIONS AND CLINICAL USE ..............................................................................3 CONTRAINDICATIONS ...................................................................................................4 WARNINGS AND PRECAUTIONS ..................................................................................4 ADVERSE REACTIONS ....................................................................................................7 DRUG INTERACTIONS ..................................................................................................10 DOSAGE AND ADMINISTRATION ..............................................................................11 OVERDOSAGE ................................................................................................................11 ACTION AND CLINICAL PHARMACOLOGY ............................................................12 STORAGE AND STABILITY ..........................................................................................12 DOSAGE
    [Show full text]
  • Preparation and Chiral HPLC Separation of the Enantiomeric Forms of Natural Prostaglandins
    Article Preparation and Chiral HPLC Separation of the Enantiomeric Forms of Natural Prostaglandins Márton Enesei 1,2,László Takács 2, Enik˝oTormási 3, Adrienn Tóthné Rácz 3, Zita Róka 3, Mihály Kádár 3 and Zsuzsanna Kardos 2,* 1 Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, M˝uegyetemrakpart 3, 1111 Budapest, Hungary; [email protected] 2 CHINOIN, a member of Sanofi Group, PG Development, Tó utca 1-5, 1045 Budapest, Hungary; laszlo.takacs@sanofi.com 3 CHINOIN, a member of Sanofi Group, PG Analytics, Tó utca 1-5, 1045 Budapest, Hungary; robertne.tormasi@sanofi.com (E.T.); adrienn.tothneracz@sanofi.com (A.T.R.); zita.roka@sanofi.com (Z.R.); mihaly.kadar@sanofi.com (M.K.) * Correspondence: zsuzsanna.kardos@sanofi.com Received: 15 June 2020; Accepted: 10 August 2020; Published: 18 August 2020 Abstract: Four enantiomeric forms of natural prostaglandins, ent-PGF α (( )-1), ent-PGE ((+)-2) 2 − 2 ent-PGF α (( )-3), and ent-PGE ((+)-4) have been synthetized in gram scale by Corey synthesis used 1 − 1 in the prostaglandin plants of CHINOIN, Budapest. Chiral HPLC methods have been developed to separate the enantiomeric pairs. Enantiomers of natural prostaglandins can be used as analytical standards to verify the enantiopurity of synthetic prostaglandins, or as biomarkers to study oxidation processes in vivo. Keywords: preparation; ent-PGF2α; ent-PGF1α; ent-PGE2; ent-PGE1; chiral HPLC; enantiomeric separation; mirror images; enantiopurity 1. Introduction Interest in the field of prostaglandins has been steadily growing since the basic work of Bergström Samuelsson, and Vane [1–3]. Their discoveries revealed the structure, the enzyme-controlled biochemical synthesis from arachidonic acid, and the main physiological effects of prostaglandins as well as their related substances.
    [Show full text]
  • Arterial Switch Operation Surgery Surgical Solutions to Complex Problems
    Pediatric Cardiovascular Arterial Switch Operation Surgery Surgical Solutions to Complex Problems Tom R. Karl, MS, MD The arterial switch operation is appropriate treatment for most forms of transposition of Andrew Cochrane, FRACS the great arteries. In this review we analyze indications, techniques, and outcome for Christian P.R. Brizard, MD various subsets of patients with transposition of the great arteries, including those with an intact septum beyond 21 days of age, intramural coronary arteries, aortic arch ob- struction, the Taussig-Bing anomaly, discordant (corrected) transposition, transposition of the great arteries with left ventricular outflow tract obstruction, and univentricular hearts with transposition of the great arteries and subaortic stenosis. (Tex Heart Inst J 1997;24:322-33) T ransposition of the great arteries (TGA) is a prototypical lesion for pediat- ric cardiac surgeons, a lethal malformation that can often be converted (with a single operation) to a nearly normal heart. The arterial switch operation (ASO) has evolved to become the treatment of choice for most forms of TGA, and success with this operation has become a standard by which pediatric cardiac surgical units are judged. This is appropriate, because without expertise in neonatal anesthetic management, perfusion, intensive care, cardiology, and surgery, consistently good results are impossible to achieve. Surgical Anatomy of TGA In the broad sense, the term "TGA" describes any heart with a discordant ven- triculoatrial (VA) connection (aorta from right ventricle, pulmonary artery from left ventricle). The anatomic diagnosis is further defined by the intracardiac fea- tures. Most frequently, TGA is used to describe the solitus/concordant/discordant heart.
    [Show full text]
  • Norwood/Batista Operation for a Newborn with Dilated Myopathy of the Left Ventricle
    612 Brief communications The Journal of Thoracic and Cardiovascular Surgery September 2000 NORWOOD/BATISTA OPERATION FOR A NEWBORN WITH DILATED MYOPATHY OF THE LEFT VENTRICLE Richard D. Mainwaring, MD, Regina M. Healy, BS, John D. Murphy, MD, and William I. Norwood, MD, PhD, Wilmington, Del Partial left ventriculectomy for dilated cardiomyopathy was contractile function. The variable results that have been first reported by Batista and associates1 in 1996. The rationale reported in the adult literature may reflect patient selection for this procedure is the increase in left ventricular cavity size according to the reversibility or recoverability of the underly- in the absence of compensatory left ventricular wall thickness ing disease process. that is observed in dilated cardiomyopathy. This combination Despite the substantial worldwide experience with the of factors results in an increase in wall stress per unit muscle Batista procedure in adult patients, there is limited experience mass, as predicted by the LaPlace equation. As wall stress with this procedure in children. The current case report increases, mechanical load eventually becomes nonsustain- describes the treatment of a patient in whom the diagnosis of able and contributes to further dilation of the ventricle. Partial dilated cardiomyopathy was made in utero. left ventriculectomy has been advocated as a method of Clinical summary. A female infant was recognized in restoring the balance between cavity size and wall thickness. utero as having a dilated, poorly functioning left ventricle. Fundamental to this concept is the assumption that the left Labor was induced at 36 weeks’ gestation, and she was deliv- ventricular muscle is intrinsically normal or has recoverable ered by normal, spontaneous, vaginal delivery.
    [Show full text]
  • The Clinical Spectrum of Fontan-Associated Liver Disease: Results from a Prospective Multimodality Screening Cohort
    Edinburgh Research Explorer The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort Citation for published version: Munsterman, ID, Duijnhouwer, AL, Kendall, TJ, Bronkhorst, CM, Ronot, M, van Wettere, M, van Dijk, APJ, Drenth, JPH & Tjwa, ETTL 2019, 'The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort', European Heart Journal, vol. 40, no. 13, pp. 1057–1068. https://doi.org/10.1093/eurheartj/ehy620 Digital Object Identifier (DOI): 10.1093/eurheartj/ehy620 Link: Link to publication record in Edinburgh Research Explorer Document Version: Peer reviewed version Published In: European Heart Journal General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 25. Sep. 2021 Title: The clinical spectrum of Fontan-Associated Liver Disease: results from a prospective multimodality screening cohort. Authors: I.D. Munsterman1, A.L. Duijnhouwer2, T.J. Kendall3, C.M. Bronkhorst4, M. Ronot5, M. van Wettere5, A.P.J. van Dijk2, J.P.H. Drenth1, E.T.T.L. Tjwa1 On behalf of the Nijmegen Fontan Initiative (A.P.J.
    [Show full text]
  • ICD-10 Coordination and Maintenance Committee Agenda
    DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 Agenda ICD-10 Coordination and Maintenance Committee Department of Health and Human Services Centers for Medicare & Medicaid Services CMS Auditorium 7500 Security Boulevard Baltimore, MD 21244-1850 ICD-10-PCS Topics March 7, 2017 Pat Brooks, CMS – Co -Chairperson Webcast and Dial-In Information The meeting will begin promptly at 9am ET and will be webcast. Toll-free dial-in access is available for participants who cannot join the webcast: Phone: 1-844-396-8222; Meeting ID: 909 233 082. We encourage you to join early, as the number of phone lines is limited. If participating via the webcast or dialing in you do NOT need to register on-line for the meeting. This meeting is being webcast via CMS at http://www.cms.gov/live/. By your attendance, you are giving consent to the use and distribution of your name, likeness and voice during the meeting. You are also giving consent to the use and distribution of any personally identifiable information that you or others may disclose about you during the meeting. Please do not disclose personal health information. Note: Proposals for diagnosis code topics are scheduled for March 8, 2017 and will be led by the Centers for Disease Control (CDC). Please visit CDCs website for the Diagnosis agenda located at the following address: http://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm 1 Introductions and Overview Pat Brooks ICD-10-PCS Topics: 1. Cerebral Embolic Protection During Michelle Joshua Transcatheter Aortic Valve Replacement Alexandra Lansky, MD Pages 10-11 Professor of Medicine, Section of Cardiology Yale School of Medicine 2.
    [Show full text]